Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation

Papers
(The TQCC of Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Impact of Coronavirus Disease 2019 and Vaccination Attitudes on Alpha-1 Antitrypsin Deficiency10
The Experiences of Individuals With a History of Acute Exacerbations of COPD and Their Thoughts on Death: Empirical Qualitative Research10
Integrating Artificial Intelligence in the Diagnosis of COPD Globally: A Way Forward7
Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study6
Bronchodilator Response in COPD: Definitions, Reference Equations, and Race6
Comparison of Chart Review and Administrative Data in Developing Predictive Models for Readmissions in Chronic Obstructive Pulmonary Disease5
Impact of Body Mass Index on the Risk of Exacerbation in Patients With COPD: A Systematic Review and Meta-Analysis5
Current-Smoking-Related COPD or COPD With Acute Exacerbation is Associated With Poorer Survival Following Oral Cavity Squamous Cell Carcinoma Surgery5
Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: Patient Experiences With Self-Infusion, Home Providers, and Clinics5
Fall Risk and Medication Use Near End of Life Among Adults With Chronic Obstructive Pulmonary Disease4
The Neutrophil-to-Lymphocyte Ratio as a Predictor of Acute Exacerbations Among Patients With COPD in Uganda4
Childhood Cigarette Smoking and Risk of COPD in Older U.S. Adults: A Nationally Representative Replication Study4
Beyond Access: Factors Associated With Spirometry Underutilization Among Patients With a Diagnosis of COPD in Urban Tertiary Care Centers4
Clinical Characteristics of Patients With COPD and Comorbid Depression and Anxiety: Data From a National Multicenter Cohort Study3
Journal Club-Respiratory Impairment With A Preserved Spirometric Ratio3
Home-based Pulmonary Rehabilitation is Effective in Frail COPD Patients with Chronic Respiratory Failure3
Factors Associated with Attrition in a Longitudinal Cohort of Older Adults in the Community3
Lung Structure and Risk of Sleep Apnea in SPIROMICS3
Circulating Exosomes and Ambient Air Pollution Exposure in COPD3
Evaluation of COPD Chronic Care Management Collaborative to Reduce Emergency Department and Hospital Revisits Across U.S. Hospitals3
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial3
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History3
The Current Landscape of COPD-Related Clinical Trials Registered on the World Health Organization’s International Clinical Trials Registry Platform: A Comprehensive Analysis of Study Characteristics a3
Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers3
Urine and Plasma Markers of Platelet Activation and Respiratory Symptoms in COPD3
Home Telemonitoring Program in Individuals With COPD During the Coronavirus Disease 2019 Pandemic: A Pilot Study3
Interleukin-17A Promotes Airway Remodeling in Chronic Obstructive Pulmonary Disease by Activating C-X-C Motif Chemokine Ligand 12 Secreted by Lung Fibroblasts3
Outcomes of Virtual Pulmonary Rehabilitation in Oxygen-Dependent COPD Patients3
Development of a Communication Instrument to Address Sexuality in COPD: COSY3
Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study3
Antibody Response to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in COPD: A Cohort Study2
Insights About the Human-Centered Design Analysis as a Tool to Improving Patients’ Tolerance with Non-Invasive Ventilation2
Respiratory Microbiome Profiles Associated With Distinct Inflammatory Phenotype and Clinical Indexes in Chronic Obstructive Pulmonary Disease2
Designing Clinical Trials in “Regular” COPD Versus Alpha-1 Antitrypsin Deficiency-Associated COPD: “More Alike Than Unalike?”2
Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency2
COPD With Lung Cancer Among Older United States Adults: Prevalence, Diagnostic Timeliness, and Association With Earlier Stage Tumors2
The Long-Term Impact of Frailty After an Intensive Care Unit Admission Due to Chronic Obstructive Pulmonary Disease2
Improving Research for COPD in Rural Areas: A Statement from the COPD Foundation Medical and Scientific Advisory Committee2
COPD: Iron Deficiency and Clinical Characteristics in Patients With and Without Chronic Respiratory Failure2
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial2
Physical Activity and Symptom Burden in COPD: The Canadian Obstructive Lung Disease Study2
RESP-FIT: A Technology-Enhanced Combined Inspiratory and Expiratory Muscle Strength Training Intervention for Adults With COPD2
Blood Eosinophil Count Stability and Clinical Outcomes in Patients With Chronic Obstructive Pulmonary Disease in a High Endemic Area of Parasitic Infection: A Prospective Study2
Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants2
Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History2
Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life2
Treatable Traits in Misdiagnosed Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination 1950 Study2
A Conceptual Framework for Use of Increased Endurance Time During Constant Work Rate Cycle Ergometry as a Patient-Focused Meaningful Outcome in COPD Clinical Trials2
COPD and Schizophrenia2
Improving Referral Patterns for Bronchoscopic Lung Volume Reduction: A Quality Improvement Initiative2
The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™)1
Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency1
The Effect of Rurality and Poverty on COPD Outcomes in New Hampshire: An Analysis of Statewide Hospital Discharge Data1
Role of Oxidative Stress and Genetic Polymorphism of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in COPD1
Differences in Sedentary Time, Light Physical Activity, and Steps Associated with Better COPD Quality of Life1
Predictors of High Sputum Eosinophils in COPD1
Exploring Clinical Control of COPD: Insights From a Portuguese Outpatient Population1
Varenicline for Gradual Versus Abrupt Smoking Cessation in Poorly Motivated Smokers With COPD: A Prematurely Terminated Randomized Controlled Trial1
Airway and Systemic Prostaglandin E2 Association with COPD Symptoms and Macrophage Phenotype1
Outcomes Important to Patients Diagnosed with Both COPD and Sleep Apnea: Findings from the O2VERLAP Study Focus Groups1
Associations Between Muscle Weakness and Clinical Outcomes in Current and Former Smokers1
Improving Dyspnea by Targeting Weight Loss in Patients With Chronic Obstructive Lung Disease and Severe Obesity Through Health Coaching and Remote Monitoring1
Effect of Two Interventional Strategies on Improving Continuous Positive Airway Pressure Adherence in Existing COPD and Obstructive Sleep Apnea Patients: The O2VERLAP Study1
Impact of an Inpatient COPD Care Pathway on Hospital Care Process and Outcome Metrics1
Variation in Prevalence and Burden of Chronic Obstructive Pulmonary Disease by State and Insurance Type in the United States1
Variations in COPD Health Care Access and Outcomes: A Rapid Review1
Impact of the Coronavirus Disease 2019 Pandemic on Physical and Mental Health of Patients With COPD: Results From a Longitudinal Cohort Study Conducted in the United States (2020-2021)1
Augmentation Therapy Modulates Systemic Inflammation in Individuals with Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease1
Health Status Progression Measured Using Weekly Telemonitoring of COPD Assessment Test Scores Over 1 Year and Its Association With COPD Exacerbations1
Chronic Obstructive Pulmonary Disease and Osteoporosis: A Two-Sample Mendelian Randomization Analysis1
Clinical Practices Surrounding the Prescription of Home Oxygen in Patients With COPD and Desaturation1
Disparities in Guideline-Concordant Statin Treatment in Individuals With Chronic Obstructive Pulmonary Disease1
Predicting COPD Progression in Current and Former Smokers Using a Joint Model for Forced Expiratory Volume in 1 Second and Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio1
Post Hoc Analysis of Lung Function Improvement and Patient-Reported Outcomes With Revefenacin in Adults With Moderate-to-Very Severe COPD and Comorbid Anxiety or Depression1
A Multimodal Intervention to Improve Guideline-Based Screening for Alpha-1 Antitrypsin Deficiency in a Community Health Setting1
Persistent Steroid Exposure Before Coronavirus Disease 2019 Diagnosis and Risk of Hospitalization in Patients With Chronic Obstructive Pulmonary Disease1
Clinical Use of an Exposure, Symptom, and Spirometry Algorithm to Stratify Smokers into COPD Risk Phenotypes: A Case-Finding Study Combined with Smoking Cessation Counseling1
Impact of Marijuana Smoking on COPD Progression in a Cohort of Middle-Aged and Older Persons1
Validation of the Onset of Effect Questionnaire in Participants With Chronic Obstructive Pulmonary Disease1
Iron Deficiency and All-Cause Hospitalization Risk in a Clinical Cohort of COPD1
Hospitalization Outcomes of Patients with Asthma, COPD, and Asthma-COPD Overlap Syndrome1
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin Deficiency1
Exploring the Patient Experience with Noninvasive Ventilation: A Human-Centered Design Analysis to Inform Planning for Better Tolerance1
Development and Validation of Machine Learning-Based Models for Prediction of Intensive Care Unit Admission and In-Hospital Mortality in Patients With Acute Exacerbations of Chronic Obstructive Pulmon1
Rural Versus Urban Health Disparities in the COVID-19 Era Among Veterans With COPD1
Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD1
Meaning in Life: A Novel Factor for Promoting Well-being in COPD1
Telerehabilitation Services Remain Increased Post-COVID-19 in Australia1
Home Non-Invasive Ventilation in COPD: A Global Systematic Review1
Inhaled Corticosteroids and Risk of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Regression1
Impact of Pharmacist Inhaler Prescribing at Discharge for Chronic Obstructive Pulmonary Disease on Readmission Rates1
0.12191605567932